Genomics announces extension of strategic drug discovery collaboration with Vertex
Genomics announced a four-year extension of its eight-year drug target discovery and validation collaboration with Vertex, beginning November 18, 2026. The total potential contract value exceeds $220 million for milestone achievements and future royalties.
Primary source
Company press release (PR Newswire), November 18, 2026
Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals
Read the source: Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals prnewswire.com
Machine-summarized from the source above; not independently reported. How we use automation